Much more than a gene: Hereditary breast and ovarian cancer, reproductive choices and family life

Medicine, Health Care and Philosophy

Volumn 16, Issue 2, 2013, Pages 231-244

  Dekeuwer, Catherine ^a   Bateman, Simone ^b  

^a UNIVERSITÉ JEAN MOULIN LYON 3   (France)

^b CNRS   (France)

Author keywords

Duties to family; Genetic predisposition to cancer; Genetic testing; Hereditary breast and ovarian cancer; Preimplantation genetic diagnosis (PGD); Reproductive choices

Indexed keywords

EID: 84876054992     PISSN: 13867423     EISSN: 15728633     Source Type: Journal    
DOI: 10.1007/s11019-011-9361-9     Document Type: Article

References (18)

1. d'Agincourt-Canning, L. 2005. The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. Journal of Genetic Counseling 14(1): 55-69.
2. d'Agincourt-Canning, L., and P. Baird. 2006. Genetic testing for hereditary cancers: The impact of gender on interest, uptake and ethical considerations. Critical Reviews in Oncology/hematology 58(2): 114-123.
3. Dekeuwer, C., and S. Bateman. 2011. Que dois-je transmettre à mes enfants? Gravité des maladies héréditaires et choix procréatifs. In Éthique et Famille (tome 2), ed. E. Rude-Antoine et M. Pievic, 143-163. Paris: L'Harmattan.
4. Fortuny, D., et al. 2009. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort. Human Reproduction 24(4): 1000-1006.
5. Hallowell, N., et al. 2003. Balancing autonomy and responsibility: The ethics of generating and disclosing genetic information. Journal of Medical Ethics 29(2): 74-79.
6. Hallowell, N., et al. 2005. Men's Decision-Making about Predictive BRCA1/2 Testing: The role of family. Journal of Genetic Counseling 14(3): 207-217.
7. Hallowell, N., et al. 2006. Guilt, blame and responsibility: Men's understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociology of Health & Illness 28(7): 969-988.
8. Levy-Lahad, E., and E. Friedman. 2007. Cancer risk among BRCA1 and BRCA2 mutation carriers. British Journal of Cancer 96(1): 11-15.
9. Menon, U., et al. 2007. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. Human Reproduction 22(6): 1573-1577.
10. Pagani, O. et al. 2011. Pregnancy after breast cancer: If you wish, ma'am. Breast Cancer Research and Treatment. doi: 10. 1007/s10549-011-1643-7. Published online: 23 June.
11. Quinn, G. P., et al. 2009. Conflict between values and technology: Perceptions of preimplantation genetic diagnosis among women at increased risk for hereditary breast and ovarian cancer. Familial Cancer 8(4): 441-449.
12. Quinn, G. P., et al. 2010a. High risk men's perceptions of pre-implantation genetic diagnosis for hereditary breast and ovarian cancer. Human Reproduction 25(10): 2543-2550.
13. Quinn, G. P., et al. 2010b. BRCA carriers' thoughts on risk management in relation to preimplantation genetic diagnosis and childbearing: when too many choice are just a difficult as none. Fertility and Sterility 94(6): 2473-2475.
14. Rowley, E. 2008. On doing 'being ordinary': Women's accounts of BRCA testing and maternal responsibility. New Genetics and Society 26(3): 241-250.
15. Staton, A. D., et al. 2008. Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. Familial Cancer 7(2): 179-186.
16. Stoppa-Lyonnet, D. et al. 2008. Diagnostic prénatal, interruption médicale de grossesse, diagnostic préimplantatoire et formes héréditaires de cancers. Rapport rédigé à la demande de l'Agence de la Biomédecine et Institut National du Cancer, 64. Avril 2008. http://www. agence-biomedecine. fr/professionnels/rapports-et-etudes-realises-autour-de-l-activite-de-dpi. html. Accessed 27 July 2011.
17. Strømsvik, N., et al. 2009. Men in the women's world of hereditary breast and ovarian cancer-a systematic review. Familial Cancer 8: 221-229.
18. Strømsvik, N., et al. 2010. Stigmatization and male identity: Norwegian males' experience after identification as BRCA1/2 mutation carriers. Journal of Genetic Counseling 19(4): 360-370.